Sunshine Biopharma, Inc.

NasdaqCM:SBFM Voorraadrapport

Marktkapitalisatie: US$5.7m

Sunshine Biopharma Beheer

Beheer criteriumcontroles 2/4

Sunshine Biopharma's CEO is Steve Slilaty, appointed in Oct 2009, has a tenure of 15.08 years. total yearly compensation is $640.00K, comprised of 59.1% salary and 40.9% bonuses, including company stock and options. directly owns 0.003% of the company’s shares, worth $173.21. The average tenure of the management team and the board of directors is 0.8 years and 3.1 years respectively.

Belangrijke informatie

Steve Slilaty

Algemeen directeur

US$640.0k

Totale compensatie

Percentage CEO-salaris59.1%
Dienstverband CEO15.1yrs
Eigendom CEO0.003%
Management gemiddelde ambtstermijnless than a year
Gemiddelde ambtstermijn bestuur3.1yrs

Recente managementupdates

Recent updates

Sunshine Biopharma, Inc.'s (NASDAQ:SBFM) 73% Dip In Price Shows Sentiment Is Matching Revenues

Mar 14
Sunshine Biopharma, Inc.'s (NASDAQ:SBFM) 73% Dip In Price Shows Sentiment Is Matching Revenues

Sunshine Biopharma, Inc.'s (NASDAQ:SBFM) Share Price Is Matching Sentiment Around Its Revenues

Jan 29
Sunshine Biopharma, Inc.'s (NASDAQ:SBFM) Share Price Is Matching Sentiment Around Its Revenues

Slammed 26% Sunshine Biopharma, Inc. (NASDAQ:SBFM) Screens Well Here But There Might Be A Catch

Sep 12
Slammed 26% Sunshine Biopharma, Inc. (NASDAQ:SBFM) Screens Well Here But There Might Be A Catch

Sunshine Biopharma acquires Nora Pharma for C$30M

Oct 20

We Think Sunshine Biopharma (NASDAQ:SBFM) Can Afford To Drive Business Growth

Aug 08
We Think Sunshine Biopharma (NASDAQ:SBFM) Can Afford To Drive Business Growth

Sunshine Biopharma reports 1H results

Aug 04

Sunshine Biopharma: Advancing Novel Cancer Therapies And Antiviral Drugs

Apr 17

Analyse CEO-vergoeding

Hoe is Steve Slilaty's beloning veranderd ten opzichte van Sunshine Biopharma's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$4m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$640kUS$378k

-US$5m

Sep 30 2023n/an/a

-US$27m

Jun 30 2023n/an/a

-US$28m

Mar 31 2023n/an/a

-US$27m

Dec 31 2022US$430kUS$360k

-US$27m

Sep 30 2022n/an/a

-US$3m

Jun 30 2022n/an/a

-US$5m

Mar 31 2022n/an/a

-US$7m

Dec 31 2021US$462kUS$156k

-US$12m

Sep 30 2021n/an/a

-US$14m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$9m

Dec 31 2020US$227kUS$177k

-US$3m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$972k

Dec 31 2019US$96kUS$28k

-US$1m

Sep 30 2019n/an/a

-US$1m

Jun 30 2019n/an/a

-US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018US$285kUS$85k

-US$2m

Sep 30 2018n/an/a

-US$2m

Jun 30 2018n/an/a

-US$1m

Mar 31 2018n/an/a

-US$1m

Dec 31 2017US$268kUS$156k

-US$1m

Compensatie versus markt: Steve's total compensation ($USD640.00K) is about average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: Steve's compensation has increased whilst the company is unprofitable.

CEO

Steve Slilaty (72 yo)

15.1yrs

Tenure

US$640,000

Compensatie

Dr. Steve N. Slilaty, Ph.D. is CEO & Chairman of Sunshine Biopharma, Inc. from October 15, 2009 and serves as President. Dr. Slilaty joined the Sunshine Biopharma, Inc. on October 15, 2009. He serves as th...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Steve Slilaty
Chairman15.1yrsUS$640.00k0.0031%
$ 173.2
Camille Sebaaly
CFO & Secretary15.1yrsUS$695.00k0.0030%
$ 170.4
Abderrazzak Merzouki
Chief Science Officer & Directorless than a yearUS$340.00k0.0029%
$ 167.5
Marc Beaudoin
Chief Operating Officerless than a yeargeen gegevensgeen gegevens
Malek Chamoun
Chief Development Officerless than a yeargeen gegevens0.093%
$ 5.3k
Robert Ferreira
President of Sunshine Bio Investments Incno datageen gegevensgeen gegevens

0.8yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren management: SBFM's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Steve Slilaty
Chairman15.1yrsUS$640.00k0.0031%
$ 173.2
Abderrazzak Merzouki
Chief Science Officer & Director8.8yrsUS$340.00k0.0029%
$ 167.5
David Natan
Independent Director2.8yrsUS$80.00kgeen gegevens
Rabi Kiderchah
Independent Director3.1yrsUS$80.00k0.000050%
$ 2.8
Andrew Keller
Independent Director2.8yrsUS$80.00kgeen gegevens

3.1yrs

Gemiddelde duur

70yo

Gemiddelde leeftijd

Ervaren bestuur: SBFM's board of directors are considered experienced (3.1 years average tenure).